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 2 
Abstract  21 
Complement C5a is associated primarily with inflammation. The widespread 22 
expression of its receptors, C5aR and C5L2 in neuronal cells, however, suggests 23 
additional regulatory roles for C5a in the CNS. C5aR agonist (PL37-MAP) evokes 24 
Ca2+-influx in GT1-7 neuronal cell line and the Ca2+-influx is regulated by estradiol. 25 
In the present study, we examined further the mechanism of Ca2+-influx and the 26 
contribution of the two estrogen receptor (ER) isotypes, ERα and ERβ, to estrogenic 27 
modulation of intracellular Ca2+-content. GT1-7 neurons were treated with isotype 28 
selective ER agonists for 24h then C5aR agonist evoked Ca2+-responses were 29 
measured by Ca2+-imaging. Transcriptional changes were followed by real-time PCR. 30 
We found that not only estradiol (100pM), but the ERα selective agonist PPT 31 
(100pM) enhanced the PL37-MAP-evoked Ca2+-influx (E2: 215%, PPT: 175%, 32 
compared to the PL37-MAP-evoked Ca2+-influx). In contrast, the ERβ selective 33 
agonist DPN (100pM) significantly reduced the Ca2+-influx (32%). Attenuated Ca2+-34 
response (25%) was observed in Ca-free environment and depletion of the Ca2+-pool 35 
by CPA eliminated the remaining elevation in the Ca2+-content, demonstrating that 36 
the majority of Ca2+ originated from the extracellular compartment. L-type voltage-37 
gated Ca2+-channel (L-VGCC) blocker nifedipine abolished the Ca2+-influx, while R-38 
type Ca2+-channel blocker SNX-482 had no effect, exemplifying the predominant role 39 
of L-VGCC in this process. Acute pre-treatments (8min) with ER agonists did not 40 
affect the evoked Ca2+-influx, revealing that the observed effects of estrogens were 41 
genomic. Therefore, we checked estrogenic regulation of C5a receptors and L-VGCC 42 
subunits. ER agonists increased C5aR mRNA expression, whereas they differentially 43 
regulated C5L2. Estradiol decreased transcription of Cav1.3 L-VGCC subunit. Based 44 
on these results we propose that estradiol may differentially modulate C5a-induced 45 
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Ca2+-influx via L-VGCCs in neurons depending on the expression of the two ER 46 
isotypes. 47 
 48 
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Abbreviations: 52 
C – complement system 53 
C5aR – “classical” complement 5a receptor (G-protein coupled) 54 
C5L2 – “second” complement 5a receptor (non-G-protein coupled) 55 
CPA – cyclopiazonic acid 56 
DPN – Diarylpropionitrile 57 
E2 – 17β-estradiol 58 
ERα – estrogen receptor alpha 59 
ERβ – estrogen receptor beta 60 
GnRH – gonadotropin-releasing hormone 61 
HBSS – Hanks’ Balanced Salt Solution 62 
L-VGCC – L-type voltage-gated calcium channel 63 
PPT – 4,4',4''-(4-Propyl-[1H]-pyrazole-1,3,5-triyl)trisphenol 64 
PVN – paraventricular nucleus 65 
SON – supraoptic nucleus 66 
 67 
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1. Introduction 69 
 The complement (C) system is an ancient immune pathway comprised of 70 
numerous elements activated in a cascade leading to the elimination of pathogens 71 
(Speth et al., 2008). During C activation, the C5a anaphylatoxin, a 74 amino-acid long 72 
fragment of the fifth component of C is released when C5 is cleaved by the C5 73 
convertase. C5a binds to two receptors, the “classical” G-protein coupled C5aR 74 
(CD88) and the non-G-protein coupled receptor C5L2 (GPR77). Both receptors are 75 
expressed on immune and non-immune cell types. C5a binding to C5aR leads to 76 
various events such as increased intracellular calcium level and activation of 77 
intracellular signaling cascades resulting in functional responses e.g. recruiting and 78 
activation of inflammatory cells, degranulation, delayed or enhanced apoptosis, 79 
phagocytosis, histamine release, and chemotaxis (Fujita et al., 2004; Guo and Ward, 80 
2005). C5L2 may function as a decoy receptor regulating the inflammatory response 81 
resulted from the C5a/C5aR binding (Bamberg et al., 2010; Woodruff et al., 2011). 82 
Expression of C5aR has been demonstrated in astrocytes, microglia and 83 
neurons of the central nervous system (CNS) (Woodruff et al., 2010). The cellular 84 
expression pattern of C5L2 is similar to that seen for C5aR. Pyramidal neurons in the 85 
hippocampus and the cortex, Purkinje cells of the cerebellum and neuroblastoma cells 86 
express C5aR (Farkas et al., 1999; Farkas et al., 1998a; Farkas et al., 1998b). Function 87 
of the C5aR in neurons remains elusive. A C5aR-related apoptotic pathway and the 88 
role of this receptor in neurodegenerative diseases such as Alzheimer’s disease have 89 
been suggested (Farkas et al., 2003; Fonseca et al., 2009; Fonseca et al., 2011). In 90 
contrast, the neuroprotective role of C5a has also been demonstrated (Woodruff et al., 91 
2010).  92 
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C5aR has recently been identified in hypothalamic neurons, including 93 
gonadotropin-releasing hormone (GnRH)-producing cells, immortalised GnRH-94 
producing GT1-7 neurons and neurons of the paraventricular (PVN) and supraoptic 95 
(SON) nuclei (Farkas et al., 2008). GT1-7 neurons establish neuronal network with 96 
co-ordinated activity and produce GnRH in a pulsatile fashion (Liposits et al., 1991; 97 
Wetsel et al., 1992). Pulsatility and volume of the secretion is in strong correlation 98 
with synchronised firing (Moenter et al., 2003; Thiery and Pelletier, 1981; Wilson et 99 
al., 1984). Various factors released during inflammation can play role in the function 100 
of these cells (Karsch et al., 2002). Cannabinoids also affect GnRH neurons by 101 
utilising the retrograde endocannabinoid signaling mechanism (Farkas et al., 2010). 102 
The estrogen receptor alpha and beta (ERα and ERβ) are expressed in 103 
numerous hypothalamic neurons, such as GnRH cells and the neurons of PVN and 104 
SON (Hrabovszky et al., 2004; Shughrue et al., 1997; Shughrue and Merchenthaler, 105 
2001), GT1-7 cells express both ER subtypes (Roy et al., 1999). 17β-estradiol (E2) 106 
can modulate the electric function of GT1-7 cells and exert both negative and positive 107 
feedback on the firing (Christian et al., 2005; Farkas et al., 2007).  108 
 Our previous experiments have shown that administration of a C5aR agonist 109 
results in robust calcium (Ca2+) influx in GnRH neurons. In addition, E2 pre-treatment 110 
elevates this Ca2+-response suggesting that the signal transduction pathways related to 111 
the C5aRs and the ERs, respectively, can modulate each other (Farkas et al., 2008). 112 
Change in the intracellular Ca2+-milieu can heavily affect firing properties of the 113 
neurons. Firing can be fine-tuned for example by the opening and closing of the L-114 
type voltage-gated Ca2+-channels (L-VGCCs). Cav1.2 and Cav1.3 subunits of the L-115 
VGCCs are strongly involved in spontaneous firing and pacemaking (Zuccotti et al., 116 
2011). In the present study, therefore, we investigated further, how C5aR and ER 117 
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subtypes interact using the immortalised GnRH-producing GT1-7 neurons as a 118 
neuronal model with Ca2+-imaging and quantitative real-time PCR methods. Genomic 119 
and non-genomic actions of ER subtypes on the C5aR-mediated Ca2+-influx were 120 
examined. Potential sources of the increased Ca2+-content were also studied, including 121 
the role of various VGCCs and the intracellular Ca2+-pool.  122 
123 
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2. Materials and methods 124 
2.1 Cell culture 125 
GnRH-producing immortalised GT1-7 neurons were cultured in Dulbecco 126 
Modified Eagle Medium (DMEM) containing high-glucose and supplemented with 127 
10% fetal calf serum (FCS) and 5% horse serum (HS). Prior to ER agonist treatment 128 
the culturing medium was replaced with a steroid/thyroid- and phenol red-free one 129 
and cells were cultured in this medium for 24hrs. Subsequently, the cells were treated 130 
with 17β-estradiol (E2, SIGMA), the highly potent ERβ receptor agonist DPN 131 
(Diarylpropionitrile, Tocris) and the ERα receptor agonist PPT (4,4',4''-(4-Propyl-132 
[1H]-pyrazole-1,3,5-triyl)trisphenol, Tocris) at various concentrations (100pM - 133 
20nM) for 24h and then used for calcium imaging and RT-PCR experiments. In the 134 
experiments examining effect of acute treatment, the E2, DPN, and PPT were added 135 
to the cells 8min before starting the calcium imaging recording. 136 
 137 
2.2 Calcium imaging 138 
Cultured GT1-7 cells were loaded with the calcium-sensitive fluorescent dye 139 
Fura-2 AM (1M; Molecular Probes, Eugene, Oregon) in loading buffer Hanks’ 140 
Balanced Salt Solution (HBSS) containing 0.1% DMSO and Pluronic-F127 (1M, 141 
Molecular Probes) for 1.5h at room temperature (RT). After washing with HBSS, the 142 
experiments were carried out at RT. The antisense homology box peptide fragment of 143 
the C5a (RAARISLGPRCIKAFTE) was synthesised in multiple antigenic peptide 144 
form (termed PL37-MAP, 2.5μM). Sequence of the PL37 is a fragment sequence of 145 
the C5a, representing a “strong” antisense homology box region in the C5a (Baranyi 146 
et al., 1995). Our previous works applying both C5a and PL37, respectively, 147 
demonstrated that PL37 is a potent agonist of the C5aR preserving the biological 148 
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activity of the C5a and triggering responses similar to that of the C5a (Baranyi et al., 149 
1996; Fujita et al., 2004). The peptide was pipetted directly onto the cells in HBSS 150 
after a 1min baseline recording and then the diluted peptide remained in the HBSS 151 
during recording. In the case of E2, DPN, PPT pre-treatment, the cells were pre-152 
treated with them as described in the “Cell culture” section and all of the rinsing and 153 
extracellular solutions contained the same concentration of E2, DPN and PPT. After 154 
the 1min baseline recording the PL37-MAP peptide was introduced into the bath fluid 155 
containing E2, DPN, and PPT and then the diluted peptide remained in the HBSS-E2 156 
or HBSS-DPN or HBSS-PPT mixture during recording.  157 
When PL37-MAP was applied in Ca2+-free extracellular solution (phosphate 158 
buffered salt solution=PBS, pH 7.4), the HBSS was changed to PBS just before 159 
starting the recording, except when the cells were treated with cyclopiazonic acid 160 
(CPA, 10μM, Tocris). CPA is a specific blocker of the Ca2+-ATP-ase of the 161 
intracellular Ca2+-store endoplasmic reticulum and depletes these Ca2+-stores. CPA 162 
was applied to the GT1-7 neurons in PBS 30min before starting the measurements.  163 
The VGCC blockers nifedipine (10μM, SIGMA) and SNX-482 (100nM) were 164 
added to the HBSS just before starting the Ca2+-imaging measurement and remained 165 
in the HBSS during recording. 166 
The experiments were carried out with an ARGUS HiSCA Ca2+-imaging 167 
system (Hamamatsu Photonics, Hamamatsu, Japan) or with an Olympus BX50WI 168 
microscope equipped with a Polychrome II monochromator (TILL Photonics), a 169 
cooled CCD camera (Photometrics Quantix, Tucson, AZ, USA), and controlled by the 170 
Axon Imaging Workbench 6.0 software (Axon Instruments, Union City, CA, USA). 171 
The ratio of the fluorescent signals obtained at excitation wavelengths of 340 and 380 172 
nm was used to determine changes in the intracellular Ca2+-concentration.   173 
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The surface density of the cultured cells was 500,000-750,000 cells/cm2, the 174 
magnification of the objective lens used was 40x, and the area of the calcium imaging 175 
acquisition was 0.038 mm2. Before starting the calcium imaging recordings, an area 176 
was chosen where at least 7 individual cells without overlaps could be clearly 177 
observed and measured (7-15 neurons depending on the surface density of the cells in 178 
the area measured). 179 
 180 
2.3 Total RNA isolation from GT1-7 cells 181 
Total RNA was isolated from GT1-7 cells using the RNeasy Mini Kit 182 
(QIAGEN, Hilden, Germany). RNA analytics included capillary electrophoresis using 183 
Agilent 2100 Bioanalyzer (Santa Clara, CA). All RNA samples displayed RNA 184 
integrity numbers (RIN) above 8.5. 185 
   186 
2.4 Quantitative real-time PCR 187 
Inventoried TaqMan assays were selected to study in depth the regulation of 188 
genes of our interest by quantitative real-time PCR. Each assay consisted of a FAM 189 
dye-labeled TaqMan MGB probe and two PCR primers. Every assay was optimised 190 
by the manufacturer to run under universal thermal cycling conditions with a final 191 
reaction concentration of 250nM for the probe and 900nM for each primer. Reverse 192 
transcription and real-time PCR were run as described earlier (Sarvari et al., 2010). 193 
RealTime StatMiner (Integromics, Granada, Spain) software and relative 194 
quantification against calibrator samples (ΔΔCt) were used for analysis of Applied 195 
Biosystems TaqMan gene expression assays. Two house-keeping genes (Gapdh, Hprt) 196 
were applied as internal controls. The geometric mean of Ct values of Gapdh and 197 
Hprt1 was used for subsequent ΔCt calculation (Vandesompele et al., 2002). Relative 198 
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quantity (RQ) represents the change in the expression of a given gene in response to a 199 
treatment compared to basal (control) expression of the given gene. We considered 200 
changes with RQ>1.5 as up-regulation or RQ<0.67 as down-regulation (21). 201 
 202 
2.5 Statistical analysis 203 
Ca2+-imaging recordings using the fluorescence ratio obtained at 340 and 380 204 
nm wavelengths were baseline corrected, then the area-under-curve data of the 205 
records representing the net Ca2+-influx were analyzed. Group data of the cells (n≥7) 206 
were expressed as mean ± standard error (SEM). Statistical significance was analyzed 207 
using ANOVA followed by Newman-Keuls (NK) test (GraphPad Software Inc., 208 
USA), and considered at p<0.05. 209 
210 
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3. Results 211 
3.1 Estrogens differentially modulate the Ca2+-influx evoked by the C5aR agonist 212 
 The C5aR agonist peptide PL37-MAP (2.5μM) triggered robust Ca2+-influx in 213 
GT1-7 neurons (Fig. 1a). Onset of the elevation of intracellular Ca2+-concentration 214 
was within 1-1.5min after application of the peptide. When the neurons were pre-215 
treated with E2 (100pM, 24h), the evoked Ca2+- influx started earlier (in less than 30 216 
seconds) and the amplitude of the records was higher than that of the recordings 217 
evoked by the PL37-MAP alone (Fig. 1b). Pre-treatment with the selective ERα 218 
agonist PPT (100pM, 24h) elevated the PL37-MAP-triggered Ca2+-influx. The 219 
elevation was similar to the increased Ca2+-influx measured with E2 (Fig. 1c). In 220 
contrast, when the cells were pre-treated with the selective ERβ agonist DPN (100pM, 221 
24h), the elevation of the Ca2+-content was much lower and started in 1.5-2min after 222 
introducing the PL37-MAP peptide into the bath fluid (Fig. 1d).  223 
 Histogram of the normalised area-under-curve data representing the net 224 
changes in the intracellular free Ca2+ concentration showed significant increase when 225 
PL37-MAP was applied to GT1-7 neurons in the presence of either E2 (100pM, 24h) 226 
or PPT (100pM, 24h), revealing facilitation of the PL37-MAP-evoked Ca2+-influx by 227 
both E2 and PPT. On the other hand, DPN (100pM, 24h) significantly decreased (Fig. 228 
1e) the Ca2+-influx evoked by PL37-MAP (E2: 226.6 ± 27.52%; PPT: 159.1 ± 229 
16.74%; DPN 18.6 ± 10.47% of the Ca2+-influx evoked by PL37-MAP alone; 230 
p<0.001). Application of higher concentrations of ER agonists resulted in similar 231 
effect except in the case of PPT (Fig. 1e). E2 (20nM, 24h) increased the PL37-MAP-232 
evoked Ca2+-influx whereas DPN (20nM, 24h) attenuated it significantly (E2: 169.7 ± 233 
16.67%; DPN 10.9 ± 3.65% of the Ca2+-influx evoked by PL37-MAP alone; 234 
p<0.001).  235 
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  236 
3.2 The effects of ER agonists on the Ca2+-influx are genomic 237 
In order to determine whether the observed effect of ER agonists on the PL37-238 
MAP-evoked Ca2+-influx was genomic, PL37-MAP was applied after an acute (8min) 239 
application of E2, PPT, and DPN. Ca2+-imaging experiments demonstrated that short 240 
administration of ER agonists failed to influence the change in the intracellular free 241 
Ca2+-concentration triggered by PL37-MAP (Fig. 1f). Examination of the area-under-242 
curve data showed no significant differences (E2: 115.1 ± 13.78%; PPT: 132.2 ± 243 
13.97%; DPN 146.9 ± 45.22% of the Ca2+-influx evoked by PL37-MAP alone). The 244 
results revealed that genomic effects of the E2, DPN, and PPT were necessary to 245 
modulate the Ca2+-response.   246 
3.3 The major Ca2+-source is extracellular 247 
 Potential sources of the increase in the intracellular Ca2+-content were also 248 
investigated with Ca2+-imaging on the GT1-7 neurons (Fig. 2a-g). Application of 249 
PL37-MAP in Ca2+-free extracellular fluid (PBS) resulted in a significantly lower 250 
Ca2+-response than in HBSS, which was independent from the ER agonist pre-251 
treatment (p<0.001). Administration of PL37-MAP resulted in a significantly 252 
attenuated elevation in Ca2+-concentration (25.3 ± 4.91% of the Ca2+-increase evoked 253 
by PL37-MAP in Ca2+-containing extracellular fluid). Nevertheless, the effect of the 254 
PL37-MAP was not entirely eliminated in PBS, suggesting, that intracellular Ca2+-255 
sources were also activated during the process. Therefore, the effect of PL37-MAP 256 
was also examined when CPA (10μM, 30min) was present in the PBS. Depletion of 257 
the Ca2+-store in the endoplasmic reticulum by CPA resulted in ablation of the 258 
increase in the intracellular free Ca2+-content (3.2 ± 0.66% of the Ca2+-increase 259 
evoked by PL37-MAP in Ca2+-containing extracellular fluid). Application of PL37-260 
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MAP in PBS in the presence of E2, DPN, or PPT (20nM, 24h) demonstrated 261 
significant decrease of the Ca2+-response (E2: 16.9 ± 1.63%; PPT: 22.9 ± 5.82%; 262 
DPN: 27.5 ± 5.45% of the Ca2+-increase evoked by PL37-MAP in Ca2+-containing 263 
extracellular fluid), however, these data did not differ from the Ca2+-increase evoked 264 
by PL37-MAP in Ca2+-free solution.  265 
3.4 L-type but not the R-type voltage-gated Ca2+-channels are involved in the PL37-266 
MAP-evoked Ca2+-influx 267 
 In order to investigate which Ca2+-channel was involved in the Ca2+-influx 268 
triggered by C5aR activation, PL37-MAP was applied to GT1-7 neurons in the 269 
presence of blockers of various VGCCs. The L- and the R-type Ca2+-channels have 270 
been reported as the most abundant ones in the GT1-7 cells (Watanabe et al., 2004), 271 
therefore these two channels were examined. Application of nifedipine (10 μM), the 272 
inhibitor of the L-VGCC, resulted in a significantly reduced Ca2+-influx evoked by 273 
PL37-MAP (Fig. 3a-f). Pre-treatment the cells with E2, PPT or DPN (20nM, 24h) did 274 
not modify effect of nifedipine (nifedipine alone: 39.7 ± 3.29%; E2: 35.8 ± 6.94%; 275 
PPT: 32.4 ± 4.66%; DPN: 34.2 ± 6.48% of the data measured with PL37-MAP alone; 276 
p<0.001).  277 
 In contrast to nifedipine, SNX-482 (100nM), the inhibitor of the R-type Ca2+-278 
channels, had no effect on the changes in the intracellular Ca2+-concentration evoked 279 
by PL37-MAP (Fig. 4a-b, f). In the presence of SNX-482, the triggered Ca2+-influx 280 
did not differ from the one measured with PL37-MAP alone (SNX: 81.6 ± 13.95 %). 281 
In addition, block of the R-type Ca2+-channels did not influence effect of the pre-282 
treatment with E2, PPT or DPN (20 nM, 24 h) (Figs. 4c-f). The Ca2+-influx increased 283 
upon E2 whereas decreased upon DPN pre-treatment significantly (E2: 139.5 ± 284 
14.63%, PPT: 86.6 ± 5.33%, DPN: 43.3 ± 6.15%, p<0.001). 285 
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 286 
3.5 Estrogenic modulation of the transcription of the C5a receptors and the Cav1.3 287 
subunit of the L-type Ca2+-channel in GT1-7 cells 288 
We examined the effects of E2 and isotype selective ER agonists on the 289 
transcription of genes encoding C5a receptors C5aR and C5L2, and L-VGCC subunits 290 
Cav1.2, and Cav1.3, by real-time PCR. We demonstrated estrogenic regulation of the 291 
C5a receptor genes (Table 1). C5ar1 (the classical C5aR) was up-regulated by the 292 
three ER agonists. C5L2 was regulated differentially, E2 increased while PPT 293 
decreased its transcription. Cacna1d (gene for Cav1.3) was regulated only by E2 294 
whereas Cacna1c (Cav1.2) showed no estrogenic regulation.  295 
296 
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4. Discussion 297 
 In the present study, we examined further estrogenic modulation of the C5aR 298 
agonist-evoked Ca2+-response using the GnRH-producing GT1-7 cell line as a 299 
neuronal model and applying isotype selective ER agonists. We demonstrated that i) 300 
ERα and ERβ agonists differentially modulated the C5aR agonist-evoked Ca2+-influx, 301 
ii) estrogenic modulation was dependent on genomic effects, iii) Ca2+-influx was 302 
mediated primarily through L-VGCC, iv) estrogens up-regulated C5aR mRNA 303 
expression while differentially regulated C5L2. 304 
4.1 Estrogens differentially modulate the PL37-MAP-evoked Ca2+-influx 305 
 Our present results showed that the C5aR agonist-evoked Ca2+-influx was 306 
differentially mediated by various ER agonists in GT1-7 neurons. Expression of 307 
C5aR, and ERα and ERβ has long been reported in various types of neurons (Farkas 308 
et al., 2003; Farkas et al., 2008; Hrabovszky et al., 2004; Hrabovszky et al., 2000; 309 
Hrabovszky et al., 2001; Shughrue et al., 1997; Shughrue and Merchenthaler, 2001; 310 
Stahel et al., 1997a; Stahel et al., 1997b; Wilson et al., 2002; Woodruff et al., 2010). 311 
Differential modulation by ERα and ERβ could be important, because Ca2+-influx 312 
evoked by the activation of C5aR can differentially affect functions of a neuronal cell, 313 
such as firing pattern, shape of after-hyperpolarisation and depolarising after-314 
potentials, neurotransmitter release, plasticity, gene transcription, and vulnerability 315 
(Berridge, 1998; Zuccotti et al., 2011).  316 
 In the present experiments DPN decreased the Ca2+-influx evoked by PL37-317 
MAP. Nevertheless, the amplitude of the inward ion current in the ERβ-expressing 318 
GnRH neurons from slices obtained from E2 substituted mice was higher than those 319 
from ovariectomized mice (Farkas et al., 2008). The reasons of the discrepancy may 320 
lie in the differences between the two models. 321 
 16 
4.2 Estrogenic modulation of the evoked Ca2+-influx is dependent on genomic effects  322 
Estrogenic modulation of the Ca2+-signal evoked by the activated C5aR was 323 
genomic rather than rapid in our experiments. Numerous estradiol-regulated genes 324 
have already been identified in GT1-7 neurons by expression profiling (Varju et al., 325 
2009). Majority of the responding genes were up-regulated in these cells, including 326 
potassium channel subunits and transporters, transcription factors, molecules related 327 
to cell death, immune response, neurotransmitter, hormone and neuropeptide 328 
receptors, regulators of G-protein signaling. Those results support our present data 329 
showing up-regulation of C5aR. 330 
In our present experiments, we found no acute effect of E2 on the Ca2+-influx 331 
evoked in the GT1-7 cells. In another model, published from another laboratory (Sun 332 
et al., 2010), both genomic and rapid changes resulted from the E2 administration 333 
were reported by potentiating the Ca2+-current in GnRH neurons in the acute brain 334 
slice in 5min. This report described, however, that percentage of the responding cells 335 
depended upon the concentration of E2 and only doses of E2 much higher than used 336 
in our experiments could evoke response with high rate of success. In, addition, the 337 
GnRH neurons presented an “all or none” ability to respond to acutely administered 338 
E2 (Sun et al., 2010). The observed discrepancies may reflect differences in the basic 339 
physiology and regulation of GnRH neurons integrated within the preoptic brain slice 340 
preparation versus the immortalised  GT1-7 neurons cultured in vitro. 341 
4.3 L-type but not R-type Ca2+-channels are involved in the PL37-MAP-evoked Ca2+-342 
influx 343 
In GT1-7 cells, the two major VGCCs are the L- and R-type channels 344 
(Watanabe et al., 2004). Both of them play a critical role in the regulation of Ca2+-345 
dependent GnRH-release. In addition, R-type Ca2+-channels have been reported to be 346 
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involved in the release of neurotransmitters in calyx-type synapses of the medial 347 
nucleus of the trapezoid body, oxytocin neurons, and adrenal chromaffin cells 348 
(Albillos et al., 2000; Wang et al., 1999; Wu et al., 1998; Wu et al., 1999). R-type 349 
channels are responsible for the dendritic Ca2+-influx induced by action potentials in 350 
CA1 pyramidal neurons of the hippocampus (Magee and Johnston, 1995; Sabatini and 351 
Svoboda, 2000). L-VGCCs contribute to Ca2+-dependent gene transcription and can 352 
modulate firing properties of neurons (Gomez-Ospina et al., 2006; Zuccotti et al., 353 
2011). Our results have now revealed that the Ca2+-ion current resulted from the 354 
activation of the C5aR in GT1-7 neurons passed through the L-VGCCs but not via R-355 
type channels. In addition, differential modulation of the Ca2+-influx by ER agonists 356 
affected the function of the L-type channel. These data suggest that physiological 357 
functions of the L-VGCC such as regulation of the GnRH release, parameters of the 358 
firing, and various gene transcriptional events are affected by C5aR activation. 359 
Modulation of the L-VGCC by E2 and DPN has recently been reported in GnRH 360 
neurons of the acute brain slice of the mice demonstrating changes in the ion current 361 
via these channels under physiological conditions (Sun et al., 2010). Similarly, 362 
modulation of the T-type voltage-gated Ca2+-channels by estradiol was also 363 
demonstrated (Bosch et al., 2009; Qiu et al., 2006; Zhang et al., 2009).  364 
It is an intriguing question, how the activation of C5aR can regulate opening 365 
of a VGCC. One possibility is a change in the threshold level by phosphorylation of 366 
the L-VGCC, occurring as a downstream event of the C5aR activation. G-protein-367 
coupled receptor activation can result in activation of diverse pathways involving 368 
enzymes such as protein kinase A or protein kinase C yielding phosphorylation of the 369 
L-VGCC, in particular its Cav1.2 or Cav1.3 subunits (Dai et al., 2009; Dolphin, 2009). 370 
This phosphorylation could eventually modify various electric parameters of the 371 
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neurons such as open probability of the channel or the threshold level. Nevertheless, 372 
the existence of a C5aR-related phosphorylation of L-VGCC requires further 373 
examination. Other G-protein mediated mechanisms can also be involved such as 374 
direct G-protein related modulation of the L-VGCCs (Currie, 2010; Tedford and 375 
Zamponi, 2006). In this paradigm, the L-VGCC molecule possesses residues 376 
interacting directly with the βγ subunits of the G-protein. The interaction is 377 
membrane-delimited, i.e. involves a second messenger molecule that remains 378 
associated with the plasma membrane, rather than diffusing to the channel via a 379 
cytoplasmic pathway (Hille, 1994). 380 
Our Ca2+-imaging measurements showed that in addition to the extracellular 381 
sources, intracellular Ca2+-stores were also involved in the elevation of the Ca2+-382 
content evoked by the activation of the C5aR. The intracellular Ca2+-stores could be 383 
triggered to release Ca2+ directly via the C5aR-related signal transduction pathway 384 
(Nishiura et al., 2010). Another possible pathway for this action is that C5aR-385 
activation opens the L-VGCCs first and then the L-VGCCs activate the intracellular 386 
Ca2+-stores via a putative coupling (Kim et al., 2007; Kolarow et al., 2007), however, 387 
these opportunities require further elaboration.   388 
 389 
4.4 C5aR agonist and estrogens modulate function of L-VGCC crucial in firing 390 
The characteristic firing pattern is a crucial feature of the hormone secreting 391 
neurons. Pulsatile release of the GnRH, for example, is indispensable for the proper 392 
function of the reproductive system (Moenter et al., 2003). In addition, the 393 
synchronous firing of the GnRH-producing neurons correlates with this pulsatility 394 
(Moenter et al., 2003). The Ca2+-channels mediates how the neurons fire, therefore, 395 
effects disturbing the intracellular Ca2+-milieu could have an effect on the firing 396 
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properties of the GnRH cells and consequently, the pulsatile secretion of GnRH. The 397 
L-VGCC is considered as one of the key mediators of the firing pattern (Zuccotti et 398 
al., 2011). Its Cav1.2 and Cav1.3 subunits expressed in neurons and endocrine cells, 399 
such as pancreatic beta, adrenal chromaffin cells (Catterall et al., 2005) and contribute 400 
to the spontaneous firing and pacemaking of the neurons (Zuccotti et al., 2011). 401 
However, literature data show activity-dependent differences between them. Cav1.3 is 402 
more effective at low levels of activity such as during interburst intervals, and Cav1.2 403 
is more efficient at high levels of activity such as during interspike intervals in the 404 
bursts (Zhang et al., 2006). It has recently been reported that E2 decreases mRNA 405 
expression of the Cav1.2, but has no effect on the Cav1.3 subunit in the hippocampus 406 
of aged female rats (Brewer et al., 2009). Our real-time PCR measurements revealed 407 
that the Cav1.3 subunit was down-regulated by E2 in GT1-7 cells. This discrepancy 408 
might originate from the cell-type differences in the two experimental models.  409 
The point of convergence of the signals coming from C5aR and ERs, was not 410 
the expression of the Ca2+-channel, because the Cav1.2 and Cav1.3 subunits were not 411 
regulated by DPN and PPT. Therefore, our present data suggest that any differential 412 
transcriptional regulation of elements of C5a/C5aR signaling which might be involved 413 
in the explored differential effects of the ER agonists on the evoked Ca2+-influx 414 
should be upstream of L-VGCC. Possible candidates could be the regulator molecules 415 
of G-protein signaling (RGS2, RGS9 and RGS 10) which were earlier shown to be 416 
regulated by E2 in the GT1-7 cells (Varju et al., 2009). 417 
4.5 C5aR is up-regulated by ER agonists  418 
In our studies, the expression of classical C5aR was up-regulated by E2 and 419 
the used isotype selective ER agonists, suggesting that neurons could respond more 420 
effectively to the inflammatory mediator C5a in the presence of estrogens. In contrast, 421 
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the expression of C5L2 was differentially regulated by ER agonists, displaying the 422 
up-regulation of this receptor by E2 and the attenuation of its expression by PPT. As 423 
the decoy receptor modulates the performance of the classical C5aR, the elucidation 424 
of this inverse regulatory trend warrants further investigation. 425 
The results of the present in vitro study raise the questions of how activation 426 
of C5aR could occur by its ligand, the C5a in hormone secreting neurons in vivo. The 427 
hypophysiotrophic axonal projections of numerous hormone secreting neurons 428 
terminate outside the blood brain barrier, suggesting that these neurons are capable of 429 
monitoring C5a released either in the hypothalamus or the blood. Since several rodent 430 
hypothalamic neurons have been shown to express functional C5a receptors (Farkas et 431 
al., 2008), it is reasonable to assume that the inflammatory mediator C5a can alter the 432 
physiological properties and cellular functions of these neurons. In these mechanisms, 433 
the Ca2+-influx occurring via L-VGCCs might have a pivotal role.  434 
 435 
436 
 21 
5. Conclusions 437 
Summing up, this study provided evidence that C5aR-mediated Ca2+-signaling 438 
can be differentially modulated via ERα and ERβ. In addition, estrogens potentiate the 439 
sensitivity of GT1-7 neurons for C5a by up-regulation of C5aR through ER and 440 
ER. C5aR activation leads to Ca2+-influx through L-VGCCs. Although the 441 
transcription of the Cav1.3 L-VGCC subunit is regulated by E2, the isotype specific 442 
ligands had no effect, indicating that these subunits are not the primary targets of ERα 443 
and ERβ agonist actions upon C5a/C5aR signaling. The significance of the present 444 
findings relates to the better understanding of the differential impact of estrogens on 445 
the C5a-evoked response of neurons which express ER and/or ER.  446 
 447 
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Figure legends 646 
Figure 1.  Ca2+-influx evoked by the C5aR agonist PL37-MAP (PL37) in the 647 
presence of E2, DPN, or PPT in the GT1-7 neurons. a) The PL37-MAP induced 648 
robust Ca2+-influx in the cells. b) Pre-treatment of the GT1-7 cells with E2 (100pM, 649 
24h) potentiated the Ca2+-influx significantly. Onset of the response started earlier and 650 
the amplitude of it was higher than without pre-treatment. c) Pre-treatment with the 651 
PPT (100pM, 24h) resulted in an elevated Ca2+-influx. d) DPN pre-treatment (100pM, 652 
24h), however, attenuated the Ca2+-influx evoked by the PL37-MAP, significantly. e) 653 
The histogram shows the area-under-curve values, representing the net Ca2+-influx in 654 
the neurons, in the percentage of the Ca2+-influx measured with the PL37-MAP alone 655 
(PL37+100 pM E2: 226,6±27,52%; PL37+100 pM PPT: 159,1±16,74%;  PL37+100 656 
pM DPN: 18,6±10,47%; PL37+20 nM E2: 169,7±16,67%; PL37+20 nM PPT: 657 
80,2±9,73%; PL37+20 nM DPN: 10,9±3,65%) f) Acute (8min) pre-treatments with 658 
the E2, DPN, or PPT showed no significant effect on the PL37-MAP-evoked Ca2+-659 
influx, demonstrating that the observed effect of E2, DPN, or PPT was genomic 660 
(PL37+E2: 115,1±13,78%; PL37+PPT: 132,1±13,97%; PL37+DPN: 146,9±45,22%). 661 
*=p<0.05, **=p<0.01. Arrow shows the onset of the administration of the PL37-662 
MAP. 663 
 664 
Figure 2.  Ca2+-influx evoked by the PL37-MAP (PL37) in the presence of CPA, 665 
E2, DPN, or PPT in the GT1-7 neurons in Ca2+-free extracellular solution. a-f) 666 
Calcium imaging recordings show that extracellular calcium sources play important 667 
role in the Ca2+-influx. g) The histogram reveals that the Ca2+-free extracellular 668 
environment decreased the Ca2+-response significantly, demonstrating that majority of 669 
the elevation in the Ca2+-concentration was from the extracellular source. This change 670 
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was independent from the pre-treatment with E2, DPN or PPT. CPA, a depletor of the 671 
Ca2+-pool in the endoplasmic reticulum, however, eliminated the remaining Ca2+-672 
response in the neurons, showing that the endoplasmic reticulum was the intracellular 673 
source of the remaining Ca2+-response (PL37 in Ca2+-free: 25.3±4.91%; PL37+CPA 674 
in Ca2+-free: 3.2±0.66%; PL37+E2 in Ca2+-free: 16.9±1.63%; PL37+PPT in Ca2+-675 
free: 22.9±5.82%; PL37+DPN in Ca2+-free: 27.5±5.45%). *=p<0.05, **=p<0.01. 676 
Arrow shows the onset of the administration of the PL37-MAP. 677 
 678 
Figure 3.  Ca2+-influx evoked by the PL37-MAP in the presence of nifedipine 679 
(blocker of L-type Ca2+-channels), E2, DPN, or PPT in the GT1-7 neurons. a-b) 680 
Calcium imaging recordings show that comparing to the control, nifedipine (Nif) 681 
eliminated the Ca2+-influx significantly. c-e) This decrease was independent from the 682 
presence of the E2, DPN, or PPT, demonstrating role of the L-type Ca2+-channels. f) 683 
The histogram of the area-under-curve data shows the values expressed in the 684 
percentage of the Ca2+-influx measured with the PL37-MAP alone (PL37+Nif: 685 
39.7±3.29%; PL37+E2+Nif: 35.8±6.94%; PL37+PPT+Nif: 32.4±4.66%; 686 
PL37+DPN+Nif: 32.4±4.66%). *=p<0.05. Arrow shows the onset of the 687 
administration of the PL37-MAP. 688 
 689 
Figure 4.  Ca2+-influx evoked by the PL37-MAP in the presence of SNX-482 690 
(blocker of R-type Ca2+-channels), E2, DPN, or PPT in the GT1-7 neurons. a-e) 691 
The ratiometric graphs revealed that SNX-482 (SNX) showed no effect on the Ca2+-692 
influx evoked by the PL37-MAP, and it exerted no influence on the effect of the ER 693 
agonists, demonstrating that the R-type Ca2+-channel plays no role in these processes. 694 
f) The histogram of the area-under-curve data shows the values expressed in the 695 
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percentage of the Ca2+-influx measured with the PL37-MAP alone (PL37+SNX: 696 
81.6±13.95%; PL37+E2+SNX: 139.5±14.63%; PL37+PPT+SNX: 86.6±5.33%; 697 
PL37+DPN+SNX: 43.3±6.15%). *=p<0.05. Arrow shows the onset of the 698 
administration of the PL37-MAP. 699 
700 
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Table legend 701 
Table 1. Transcriptional modulation of L-type Ca2+-channel subunits and C5a 702 
receptors. Transcription of L-type Ca2+-channel Cav1.2 (Cacna1c) and Cav1.3 703 
(Cacna1d) subunits, and C5a receptors CD88 (C5ar1) and C5L2 (Gpr77) was 704 
followed by real-time PCR. Table shows the arithmetic mean and standard deviation 705 
of relative quantities (RQ) from two independent experiments. Arrows show direction 706 
of regulation of the respective transcript where change is significant. The lack of 707 
evidence for regulation is denoted with “-“.  708 
 709 
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 720 
Gene symbol and  
physiologic name  
E2 PPT DPN 
Cacna1c (L-type Ca2+-
channel Cav1.2 subunit) 
0.867±0.164 - 0.905±0.073 - 0.748±0.052 - 
Cacna1d (L-type Ca2+-
channel Cav1.3 subunit) 
0.413±0.326  0.960±0.023 - 0.795±0.117 - 
C5ar1 (C5aR) 2.476±0.715 
 
2.039±0.241 
 
1.938±0.743 
 
Gpr77 (C5L2) 1.634±0.336 
 
0.562±0.101 
 
0.955±0.577 - 
 721 
 722 
 723 
Table 1. 724 
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